CLINDAMYCINE SUBSTIPHARM 300 mg, hard capsule 16 capsules
Active ingredients: Clindamycin hydrochloride monohydrate, Clindamycin
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule16 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLINDAMYCINE SUBSTIPHARM 300 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 16 gélules
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60985976CIP73030263CIP133400930302637Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLINDAMYCINEgélule | 300 mg · une gélule | FT |
| CHLORHYDRATE DE CLINDAMYCINE HYDRATÉgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.